LONG-TERM EFFECTIVENESS AND ACCEPTABILITY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: THE REMSWITCH-LT STUDY

Anthony Buisson  ¹     Maria Nachury  ²     Maëva Bazoges     Clara Yzet  ³     Pauline Wils  ⁴     Marie Dodel     Dilek Coban     Bruno Pereira     Mathurin Fumery    
¹ CHU Estaing Clermont-Ferrand, Clermont-Ferrand, France
² CHRU Lille, Courbevoie Cedex, France
³ Amiens University Hospital, Amiens, France
⁴ CHRU Lille, Lille Cedex, France

Topic
IBD

Session
The switch game: Optimal treatment modalities in IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)